What are ResMed's profit margins?

ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.

Where do ResMed's ratios come from?

Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ResMed RMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q3 '26	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Profitability
Gross margin	61.6%+2.8pp	60.9%+2.5pp	60.1%+2.4pp	59.4%+2.7pp	58.8%+3.0pp
Operating margin	34.2%+2.1pp	33.7%+2.0pp	33.2%+3.7pp	32.7%+4.6pp	32.1%+5.6pp
Net margin	27.4%+1.3pp	27.5%+2.2pp	27.4%+4.2pp	27.2%+5.4pp	26.2%+5.2pp
EBITDA margin	38.2%+2.5pp	37.5%+2.2pp	37%+3.8pp	36.6%+4.7pp	35.7%+5.3pp
Free cash flow margin	31.7%+0.4pp	33.2%+4.9pp	33.6%+5.5pp	32.3%+4.5pp	31.2%+7.5pp
Returns
Return on equity	25.2%-0.6pp	25.7%0.0pp	25.4%+1.8pp	25.9%+3.2pp	25.8%+3.4pp
Return on assets	18.6%+0.3pp	19%+1.2pp	18.5%+2.6pp	18.6%+3.6pp	18.3%+4.1pp
Return on invested capital	26.5%+2.2pp	25.6%+3.1pp	25.1%+4.6pp	25.3%+5.9pp	24.3%+6.5pp
Efficiency
Asset turnover	0.7×0.0×	0.7×0.0×	0.7×0.0×	0.7×0.0×	0.7×0.0×
Inventory turnover	2.4×-0.1×	2.3×+0.1×	2.3×+0.1×	2.4×+0.2×	2.4×+0.2×
Liquidity
Current ratio	3×-0.4×	3.1×-0.3×	2.9×0.0×	3.4×+0.9×	3.4×+0.4×
Quick ratio	2.3×-0.2×	2.3×0.0×	2.1×+0.2×	2.5×+0.8×	2.5×+0.5×
Cash ratio	1.2×+0.2×	1.1×+0.5×	1.1×+0.6×	1.2×+0.9×	1×+0.7×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.1×0.0×	0.2×-0.1×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×-0.1×
Net debt / EBITDA	-0.3×-0.2×	-0.2×-0.3×	-0.1×-0.4×	-0.2×-0.6×	-0×-0.7×
Interest coverage	54.4×—	78.1×—	119.8×—	409.7×—	——
Per Share
Book value per share	$44.55+18.3%	$43.18+21.2%	$41.67+18.4%	$40.50+22.9%	$37.67+20.0%
Valuation
Market capitalization	$32.7B-0.5%	$35.16B+4.7%	$40.08B+11.7%	$37.52B+33.4%	$32.88B+13.0%
Enterprise value	$32.14B-2.0%	$34.85B+2.8%	$39.8B+9.6%	$37.18B+29.2%	$32.79B+9.2%
Price / earnings	21.5×-3.5×	23.7×-3.2×	27.9×-4.4×	26.8×-0.8×	25×-5.3×
Price / sales	5.9×-0.6×	6.5×-0.3×	7.6×+0.2×	7.3×+1.3×	6.5×+0.2×
Price / book	5×-0.9×	5.6×-0.8×	6.5×-0.4×	6.3×+0.5×	5.9×-0.4×
EV / EBITDA	15.2×-3.1×	17.2×-2.3×	20.5×-2.3×	19.7×+0.5×	18.3×-3.2×
EV / sales	5.8×-0.7×	6.5×-0.4×	7.6×0.0×	7.2×+1.1×	6.5×0.0×
Free cash flow yield	5.4%+0.6pp	5.1%+1.0pp	4.4%+0.6pp	4.4%-0.2pp	4.8%+1.0pp
Earnings yield	4.6%+0.7pp	4.2%+0.5pp	3.6%+0.5pp	3.7%+0.1pp	4%+0.7pp
Dividend yield	1%+0.1pp	0.9%+0.1pp	0.8%0.0pp	0.8%-0.2pp	0.9%0.0pp
PEG ratio	1.4×+0.7×	1.2×+0.6×	1×-0.5×	0.7×-1.3×	0.7×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ResMed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ResMed's profit margins?: ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?: Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.